Home > Companies > IKARIA Inc

IKARIA Inc


1616 Eastlake Ave E Suite 340
Seattle, WA 98102 United States
Phone:(206) 436-5000
[Save to my library]

Overview: At Ikaria, we are positioned to develop and deliver innovative therapeutics and interventions to meet the significant needs of critically ill patients. It is our aim to be an indispensable partner to clinicians, providing help and critically caring just when patients need it the most.
Being part of this lifeline, our desire is to have an impact on the lives of critically ill patients, wherever they may be. Delivering effective and efficient therapies is our way of serving and supporting these patients.
UMDC Code: 452052
Fax: (206) 436-5001
Email: info@ikaria.com
Website: http://www.ikaria.com
Company Type: Private
Business Started: 2005
Business Lines: Manufacturer
Sales Channels: Direct
Categories:

Company Rating Be the first to rate this company! You must sign in.

INOMAX (NITRIC OXIDE) FOR INHALATION
he first of our growing list of critical care therapies is INOMAX, an effective intervention for term and near-term infants who suffer from hypoxic respiratory failure (HRF) associated with pulmonary hypertension.1 Since its commercialization in 2000, we believe that over 450,000 patients have been treated with INOMAX worldwide.2
Read More

INOMAX (NITRIC OXIDE) FOR INHALATION
INOMAX is approved by the FDA to treat term and near-term (greater than 34 weeks) infants with HRF associated with pulmonary hypertension. INOMAX is an inhaled drug that helps to relax or open up the blood vessels of the lungs in newborns. This, in turn, helps the infants heart and lungs process more oxygen and deliver more oxygenated blood to the rest of the body.2
Read More

INOMAX (NITRIC OXIDE) FOR INHALATION
From the moment it was discovered, nitric oxide has inspired countless researchers and clinicians to realize the benefits of this vasodilator. At Ikaria, we too are inspired by this Nobel Prize-winning discovery and are dedicated to realizing its full potential. When administered as an inhaled drug, nitric oxide is the only drug that selectively dilates the pulmonary vasculature.1
Read More

No results at this time

Please provide the following information and a representative of IKARIA Inc will contact you to assist with any questions you might have.


Medical Product Guide Ophthalmology Management Product Guide